Howard Lutnick, the head of investment bank Cantor Fitzgerald and financial-technology company BGC Group, is breaking into ...

Louise Chen, Cantor Fitzgerald senior analyst, joins ‘Squawk Box’ to discuss Novo Nordisk's CEO on Capitol Hill, when drug ...

Cantor Fitzgerald initiated coverage of Amgen with an Overweight rating and $405 price target. The firm views Amgen’s obesity ...

Fintel reports that on September 27, 2024, Cantor Fitzgerald initiated coverage of Amgen (NasdaqGS:AMGN) with a Overweight ...

Now a $54 billion investment firm is in the mix. By Matthew Goldstein For a Cantor Fitzgerald lawyer, a summer ritual in Central Park is a reminder of how New York can heal the hurting.

We recently compiled a list of Cantor Fitzgerald’s Top Internet Stocks: Best Stocks To Buy According To $13.2 Billion Firm.

Cantor Fitzgerald has recently initiated Innoviva Inc (INVA) stock to Overweight rating, as announced on June 18, 2024, according to Finviz. Earlier, on July 20, 2022, Goldman had initiated the stock ...

Cantor Fitzgerald analyst Pete Stavropoulos maintained a Buy rating on Vera Therapeutics (VERA – Research Report) yesterday and set a ...

In a report released on September 20, Ross Osborn from Cantor Fitzgerald reiterated a Buy rating on Nano-X Imaging (NNOX – Research ...

Cantor Fitzgerald Managing Director Louise Chen noted that price of weight loss drugs from Novo Nordisk and Eli Lilly should ...